Page last updated: 2024-08-21

pyrazines and milrinone

pyrazines has been researched along with milrinone in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19901 (10.00)18.7374
1990's8 (80.00)18.2507
2000's1 (10.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baughman, KL; Feldman, AM; Strobeck, JE1
Lugnier, C; Muller, B; Stoclet, JC1
Blinks, JR; Endoh, M; Taira, N; Yanagisawa, T1
Han, W; Qin, Y; Yang, Z; Zhang, Z; Zhou, S1
Lan, T; Li, H; Zeng, X; Zhang, Y1
Bonnet, PA; Crilley, TK; Wanstall, JC1
Jeffery, TK; Wanstall, JC1
Pritzker, MR1
Battagliese, A; Bucciarelli Ducci, C; Celotto, A; De Luca, L; Fedele, F; Palombaro, GL; Proietti, P1

Reviews

1 review(s) available for pyrazines and milrinone

ArticleYear
New positive inotropic agents in the treatment of left ventricular dysfunction.
    Italian heart journal : official journal of the Italian Federation of Cardiology, 2004, Volume: 5 Suppl 6

    Topics: Cardiotonic Agents; Diastole; Heart Failure; Humans; Hydrazones; Milrinone; Myocardial Ischemia; Phosphodiesterase Inhibitors; Pyrazines; Pyridazines; Quinolines; Simendan; Ventricular Dysfunction, Left; Ventricular Function, Left

2004

Trials

1 trial(s) available for pyrazines and milrinone

ArticleYear
Oral milrinone in severe chronic heart failure.
    The New England journal of medicine, 1992, Jun-04, Volume: 326, Issue:23

    Topics: Cardiotonic Agents; Heart Failure; Humans; Milrinone; Pyrazines; Pyridones; Quinolines

1992

Other Studies

8 other study(ies) available for pyrazines and milrinone

ArticleYear
Implication of cyclic AMP in the positive inotropic effects of cyclic GMP-inhibited cyclic AMP phosphodiesterase inhibitors on guinea pig isolated left atria.
    Journal of cardiovascular pharmacology, 1990, Volume: 15, Issue:3

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 8-Bromo Cyclic Adenosine Monophosphate; Animals; Calcium Chloride; Cardiotonic Agents; Colforsin; Cyclic AMP; Cyclic GMP; Guinea Pigs; Imidazoles; In Vitro Techniques; Isoproterenol; Male; Milrinone; Myocardial Contraction; Myocardium; Protoveratrines; Pyrazines; Pyridones; Sodium

1990
Effects of new inotropic agents on cyclic nucleotide metabolism and calcium transients in canine ventricular muscle.
    Circulation, 1986, Volume: 73, Issue:3 Pt 2

    Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Aequorin; Aminopyridines; Amrinone; Animals; Calcium; Carbachol; Cardiotonic Agents; Colforsin; Cyclic AMP; Dogs; Dose-Response Relationship, Drug; Enoximone; Female; Imidazoles; Male; Milrinone; Myocardial Contraction; Myocardium; Nifedipine; Nucleotides, Cyclic; Pyrazines; Pyridones; Quinolines; Time Factors

1986
[Inotropic effect of novel domestic cardiotonic agent, vesnarinone--test in vitro].
    Hua xi yi ke da xue xue bao = Journal of West China University of Medical Sciences = Huaxi yike daxue xuebao, 1994, Volume: 25, Issue:3

    Topics: Amrinone; Animals; Cardiotonic Agents; Dose-Response Relationship, Drug; Female; Guinea Pigs; In Vitro Techniques; Male; Milrinone; Myocardial Contraction; Pyrazines; Pyridones; Quinolines; Rabbits; Stimulation, Chemical

1994
[Effects of vesnarinone on L-type single Ca2+ channel current in cultured ventricular myocytes of embryonic chick].
    Hua xi yi ke da xue xue bao = Journal of West China University of Medical Sciences = Huaxi yike daxue xuebao, 1995, Volume: 26, Issue:4

    Topics: Animals; Calcium Channels; Cardiotonic Agents; Cells, Cultured; Chick Embryo; Milrinone; Myocardium; Patch-Clamp Techniques; Phosphodiesterase Inhibitors; Pyrazines; Pyridones; Quinolines

1995
Vasorelaxant effects of SCA40 (a phosphodiesterase III inhibitor) in pulmonary vascular preparations in rats.
    Clinical and experimental pharmacology & physiology, 1998, Volume: 25, Issue:5

    Topics: 1-Methyl-3-isobutylxanthine; 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Cyclic Nucleotide Phosphodiesterases, Type 3; Guinea Pigs; Imidazoles; Male; Milrinone; Muscle, Smooth, Vascular; Parasympatholytics; Phosphodiesterase Inhibitors; Potassium Channel Blockers; Pulmonary Artery; Pyrazines; Pyridones; Rats; Rats, Wistar; Trachea; Vasodilation; Vasodilator Agents

1998
Phosphodiesterase III and V inhibitors on pulmonary artery from pulmonary hypertensive rats: differences between early and established pulmonary hypertension.
    Journal of cardiovascular pharmacology, 1998, Volume: 32, Issue:2

    Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Colforsin; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 5; Female; Hypertension, Pulmonary; Hypoxia; Imidazoles; Male; Milrinone; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pulmonary Artery; Pyrazines; Pyridones; Rats; Rats, Wistar; Vasodilation

1998
Severe heart failure: balancing length and quality of life.
    Harvard heart letter : from Harvard Medical School, 1999, Volume: 9, Issue:10

    Topics: Amrinone; Cardiotonic Agents; Heart Failure; Humans; Milrinone; Phosphodiesterase Inhibitors; Pyrazines; Quality of Life; Quinolines

1999
Chronic heart failure and the quality of life.
    The New England journal of medicine, 1999, May-13, Volume: 340, Issue:19

    Topics: Cardiotonic Agents; Heart Failure; Humans; Milrinone; Palliative Care; Pyrazines; Quality of Life; Quinolines

1999